Search for Clinical Trial Results
Scleroderma, Diffuse - 20 Studies Found
Status | Study |
Completed |
Study Name: Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis Condition: Systemic Sclerosis Date: 2008-04-23 |
Recruiting |
Study Name: Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma Condition: Scleroderma Date: 2015-01-26 Interventions:
|
Completed |
Study Name: Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis Condition: Systemic Sclerosis Date: 2012-08-15 Interventions: Drug: Belimumab Belimumab (Benlysta®) decreases B-Cell survival and has been FDA approved for the t |
Completed |
Study Name: A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) Condition:
|
Completed |
Study Name: Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement Condition: Scleroderma, Systemic Date: 2006-06-02 Interventions: Drug: Mycophenolate mofetil |
Active, not recruiting |
Study Name: IVIG Treatment in Systemic Sclerosis Condition:
|
Recruiting |
Study Name: Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial Condition: Scleroderma Date: 2011-09-29 Interventions:
|
Completed |
Study Name: Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial Condition: Systemic Scleroderma Date: 2015-01-18 Interventions:
|
Recruiting |
Study Name: Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Patients With Severe Systemic Sclerosis Condition:
|
Completed |
Study Name: High Dose Cyclophosphamide for Treatment of Scleroderma Condition: Scleroderma Date: 2007-07-13 Interventions: Drug: IV Cyclophosphamide Cyclophosphamide (50 mg/kg) intravenously daily for 4 consecutive days (total |